A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults
Clinical trial NCT03201211 · COMPLETED
Trial details
- NCT number
- NCT03201211
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2020-03-19
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.